Cashing In On A Changed World
At some point, life will return to something resembling what it did before the coronavirus pandemic. Or at least, some aspects of life will. Others,… Read More »Cashing In On A Changed World
Investors
What’s Really Driving Stock Returns (And Signaling More Upside Ahead)?
Despite the narrative to the contrary, higher levels of activity by individual investors during the pandemic has not been boosting stock prices, according to Goldman… Read More »What’s Really Driving Stock Returns (And Signaling More Upside Ahead)?
Trump Or Biden, These Health-Care Stocks Should Thrive
As coronavirus infections rise across a large swath of the country, so too do the Democrats’ election prospects, which creates a great deal of uncertainty… Read More »Trump Or Biden, These Health-Care Stocks Should Thrive
A Wrinkle In Reopening Creates A New Puzzle For Investors
With coronavirus cases surging in many parts of the country, the reopening process has halted in several states – and this development has created a… Read More »A Wrinkle In Reopening Creates A New Puzzle For Investors
Timeline To $1,000
Generating $1,000 in monthly dividend income is a worthy goal. The question is, how long should you expect it to take to achieve it? CLICK… Read More »Timeline To $1,000
A Playbook For Continued Volatility – And The Best Down Day Bets
If volatility remains high, making the right sector, industry and stock selections will be especially important. Here’s an up day/down day playbook, including what may… Read More »A Playbook For Continued Volatility – And The Best Down Day Bets
Crash-Tested Stock Qualities
While the stock market has experienced a significant recovery from the March crash, “there are any number of ways stocks could be primed for another… Read More »Crash-Tested Stock Qualities
The Dividend Danger Zone
There are solid dividend-paying stocks out there, but these seven dividend stocks may not be among them. In fact, amid the COVID-19 crisis, these stocks… Read More »The Dividend Danger Zone
AbbVie’s 3 For 3
Drugmaker AbbVie scored three big wins in recent days – one in the courtroom, one in a clinical study, and one in the form of… Read More »AbbVie’s 3 For 3
COVID-19’s Potentially Long-Lasting Impact On ESG Investing
While it was already attracting an increasing amount of investor attention – and money – before the coronavirus outbreak, the global pandemic could prove to… Read More »COVID-19’s Potentially Long-Lasting Impact On ESG Investing